Literature DB >> 7077617

Identification and characterization of early and late prescribers in general practice.

B Strickland-Hodge, M H Jepson.   

Abstract

National Health Service prescriptions written by general medical practitioners in one urban Area were analysed over a fifteen-month period to classify doctors into those who prescribed a named drug early or relatively later in its market life. A questionnaire, designed to answer a number of hypotheses intended to characterize these groups of practitioners, was mailed to the 100 doctors in each group. Statistical analysis of the results suggests that there are several identifiable characteristic differences between `early' and `late' prescribers. Early prescribers have larger list sizes than late prescribers and rely more on industrial sources for information about drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077617      PMCID: PMC1437765          DOI: 10.1177/014107688207500510

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  4 in total

1.  Do drug advertisements provide therapeutic information?

Authors:  G V Stimson
Journal:  J Med Ethics       Date:  1977-03       Impact factor: 2.903

2.  The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs.

Authors:  E Hemminki
Journal:  Med Care       Date:  1974-04       Impact factor: 2.983

3.  Physicians' drug innovation and relinquishment.

Authors:  R E Mapes
Journal:  Soc Sci Med       Date:  1977-09       Impact factor: 4.634

4.  Prescribing in Northern Ireland. Study no. 1: Sleeping tablets.

Authors:  P C Elmes; H Hood; C McMeekin; O L Wade
Journal:  Ulster Med J       Date:  1976
  4 in total
  7 in total

1.  Prescribing new drugs: qualitative study of influences on consultants and general practitioners.

Authors:  M I Jones; S M Greenfield; C P Bradley
Journal:  BMJ       Date:  2001-08-18

2.  Access to new medications to treat schizophrenia.

Authors:  Tami L Mark; Riad Dirani; Eric Slade; Patricia A Russo
Journal:  J Behav Health Serv Res       Date:  2002-02       Impact factor: 1.505

Review 3.  Interactions between physicians and the pharmaceutical industry: what does the literature say?

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-11-15       Impact factor: 8.262

4.  A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?

Authors:  Roberto Cardarelli; John C Licciardone; Lockwood G Taylor
Journal:  BMC Fam Pract       Date:  2006-03-03       Impact factor: 2.497

5.  The role of the hospital consultant in general practitioner prescribing.

Authors:  B Strickland-Hodge; M H Jepson
Journal:  J R Soc Med       Date:  1988-04       Impact factor: 18.000

6.  What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Authors:  Mustafa Ali Alssageer; Stefan Robert Kowalski
Journal:  Pan Afr Med J       Date:  2013-04-06

7.  Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study.

Authors:  Satnam K Virdee; Sheila M Greenfield; Kate Fletcher; Richard J McManus; F D Richard Hobbs; Jonathan Mant
Journal:  BMJ Open       Date:  2013-03-25       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.